European post-marketing observational prospective cohort study of children with type I diabetes treated with Apidra.
Phase of Trial: Phase IV
Latest Information Update: 25 Jul 2016
At a glance
- Drugs Insulin glulisine (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Sanofi
- 06 May 2012 Additional lead trial investigator (Dr Stephen Greene) identified ans additional locations (England, Scotland) identified as reported by United Kingdom Clinical Research Network record.
- 06 May 2012 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network record.
- 23 Jun 2009 New trial record